Evaluating the Safety and Efficacy of Asundexian in Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background Thromboembolic events remain a major cause of morbidity and mortality in cardiovascular diseases, particularly myocardial infarction, atrial fibrillation (AF), and ischemic stroke. While standard anticoagulants reduce these events, their use is limited by bleeding risks. Asundexian, a Fac...

Полное описание

Библиографические подробности

Главные авторы:	Zainab Arif MBBS, Muhammad Ashbar Wadood MBBS, Sania Malahat MBBS, Mehmood Ahmad MBBS, Maliha Khalid MBBS, Saman Adnan MBBS, Erum Siddiqui MBBS, Aminath Waafira MBBS
Формат:	Artigo
Язык:	Inglês
Опубликовано:	SAGE Publishing 2025-07-01
Серии:	Clinical and Applied Thrombosis/Hemostasis
Online-ссылка:	https://doi.org/10.1177/10760296251365238
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!